cholestane-3,5,6-triol has been researched along with alkenes in 1 studies
| Studies (cholestane-3,5,6-triol) | Trials (cholestane-3,5,6-triol) | Recent Studies (post-2010) (cholestane-3,5,6-triol) | Studies (alkenes) | Trials (alkenes) | Recent Studies (post-2010) (alkenes) |
|---|---|---|---|---|---|
| 83 | 0 | 20 | 10,589 | 26 | 5,109 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kummerow, FA; Mahfouz, MM | 1 |
1 other study(ies) available for cholestane-3,5,6-triol and alkenes
| Article | Year |
|---|---|
Oxysterols and TBARS are among the LDL oxidation products which enhance thromboxane A2 synthesis by platelets.
Topics: Alkenes; Arachidonic Acid; Blood Platelets; Carbon Radioisotopes; Cholestanols; Cholesterol; Humans; Lipoproteins, LDL; Oxidation-Reduction; Sterols; Thiobarbituric Acid Reactive Substances; Thrombin; Thromboxane A2; Vitamin E | 1998 |